前收市價 | 146.82 |
開市 | 146.70 |
買盤 | 145.88 x 1100 |
賣出價 | 146.14 x 800 |
今日波幅 | 145.95 - 147.18 |
52 週波幅 | 143.13 - 175.97 |
成交量 | |
平均成交量 | 7,640,096 |
市值 | 352.165B |
Beta 值 (5 年,每月) | 0.53 |
市盈率 (最近 12 個月) | 19.70 |
每股盈利 (最近 12 個月) | 7.42 |
業績公佈日 | 2024年7月17日 |
遠期股息及收益率 | 4.96 (3.39%) |
除息日 | 2024年5月20日 |
1 年預測目標價 | 173.75 |
AbbVie's (ABBV) first-quarter earnings and sales beat estimates. Management hikes the EPS guidance on the back of encouraging Skyrizi product sales.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.
Five stocks to focus with recent dividend hike are: JNJ, TRV, SON, KBH, SPFI.